Connect with us

Subscribe

Cancer

liposome-encapsulated irinotecan hydrochloride PEP02

A form of the anticancer drug irinotecan hydrochloride that is contained in very tiny, fat-like particles. Liposome-encapsulated irinotecan hydrochloride PEP02 is used together with fluorouracil and leucovorin to treat a certain type of pancreatic cancer that has spread to other parts of the body and has gotten worse after treatment with gemcitabine anticancer therapy. It is also being studied in the treatment of other types of cancer. Irinotecan hydrochloride blocks certain enzymes needed for cell division and DNA repair, and it may kill cancer cells. Liposome-encapsulated irinotecan hydrochloride PEP02 may have fewer side effects and work better than irinotecan hydrochloride. It is a type of topoisomerase inhibitor and a type of camptothecin analog. Also called irinotecan hydrochloride liposome, Onivyde, and PEP02.

Source: NCI Dictionary of Cancer Terms

Search the Glossary of Medical Terms

liposome
LipoTaxen
Newsletter

Sign up for the QuackTrack.org newsletter below!

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

QuackTrack on Twitter

Trending Posts

Connect
Newsletter

Sign up for the QuackTrack.org newsletter below!